この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
規制と法律 · 1996/12/171 分で読めます
Roche Molecular Systems, Inc.; Premarket Approval of Roche Amplicor HIV-1 Monitor Test
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is announcing its approval of the application by Roche Molecular Systems, Inc., Somerville, NJ, for premarket approval, under the Federal Food, Drug, and Cosmetic Act (the act), of the Roche Amplicor HIV-1 Monitor Test. After reviewing the recommendation of the Blood Products Advisory Committee (BPAC), FDA's Center for Biologics Evaluation and Research (CBER) notified the applicant, by letter of June 3, 1996, of the approval of the application.
情報源の原言語: Federal Register — All Documents原文の発表を開く →